SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-23-014357
Filing Date
2023-11-14
Accepted
2023-11-14 16:07:01
Documents
57
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ndra_10q.htm   iXBRL 10-Q 686390
2 CERTIFICATION ndra_ex311.htm EX-31.1 10483
3 CERTIFICATION ndra_ex312.htm EX-31.2 10261
4 CERTIFICATION ndra_ex321.htm EX-32.1 4760
  Complete submission text file 0001654954-23-014357.txt   3222524

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ndra-20230930.xsd EX-101.SCH 39442
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ndra-20230930_lab.xml EX-101.LAB 221139
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ndra-20230930_cal.xml EX-101.CAL 35363
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ndra-20230930_pre.xml EX-101.PRE 184119
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ndra-20230930_def.xml EX-101.DEF 100265
51 EXTRACTED XBRL INSTANCE DOCUMENT ndra_10q_htm.xml XML 372571
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37969 | Film No.: 231406055
SIC: 3845 Electromedical & Electrotherapeutic Apparatus